Verified source report

Muscle growth drug ‘could reduce loss of lean tissue’ when using slimming jabs

Trial suggests monoclonal antibody can help retain lean body mass when losing weight with GLP-1 medicines A drug that promotes muscle growth could significantly reduce the loss of lean body mass when using slimming jabs, research suggests. While GLP-1 based jabs such as Wegovy and Mounjaro have proved highly effective at helping people who are overweight or obese, experts have warned it is not only fat that is lost. Studies suggest 25-40% of total weight loss is down to a reduction in lean body mass – non-fat components of the body, including muscle. Continue reading...

Source-feed image associated with Muscle growth drug ‘could reduce loss of lean tissue’ when using slimming jabs
Source-feed image associated with the linked report: Muscle growth drug ‘could reduce loss of lean tissue’ when using slimming jabs.Credit: The Guardian Source-feed thumbnail displayed with attribution and outbound source link; VINI does not claim ownership or republish the third-party article body. Image source Cached source-feed image shown for continuity with attribution and an outbound source link; VINI does not claim third-party image authorship or republish the third-party article body.

What happened

According to The Guardian’s source item, Muscle growth drug ‘could reduce loss of lean tissue’ when using slimming jabs, Trial suggests monoclonal antibody can help retain lean body mass when losing weight with GLP-1 medicines A drug that promotes muscle growth could significantly reduce the loss of lean body mass when using slimming jabs, research suggests. While GLP-1 based jabs such as Wegovy and Mounjaro have proved highly effective at helping people who are overweight or obese, experts have warned it is not only fat that is lost. Studies suggest 25-40% of total weight loss is down to a reduction in lean body mass – non-fat components of the body, including muscle. Continue reading…

Context

The development sits in VINI’s Science file for readers following research, health, climate, space, medicine, and scientific institutions. The original report is linked so readers can check the source account, follow later updates, and compare new coverage against the first published record. The source item is dated 2026-06-08T15:00:30+00:00.

What to watch

Open questions include whether primary sources issue follow-up statements, whether local or market impacts become clearer, and whether additional reporting changes the timeline or adds material context.

Source

Primary source: Muscle growth drug ‘could reduce loss of lean tissue’ when using slimming jabs via The Guardian. VINI cites and links the source; it does not reproduce the publisher’s full article text without rights clearance.

This source-cited VINI report links to the original publisher record. VINI does not republish third-party article bodies without rights clearance. 1 source listed.

Source links

Reader comments

Moderated discussion

Account access

Comments are open to authenticated approved accounts, screened for spam and abuse, and published only after newsroom moderation unless editors change the story control.

Loading comments.